コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 macological phenomenon that occurs after its prolonged administration.
2 warranted to assess efficacy and toxicity of prolonged administration.
3 m diminished efficacy to reduce weight after prolonged administration.
4 ns worldwide, yet current treatments require prolonged administration.
5 and non-Hodgkin lymphoma (NHL), they require prolonged administration and provide incomplete response
6 rugs exert mood-elevating effects only after prolonged administration, and a sizable fraction of the
7 entavalent antimonials are toxic and require prolonged administration, leading to poor patient compli
8 which suggests that alternate schedules with prolonged administration may be necessary for further cl
9 ns in neocortical activation after acute and prolonged administration of acetylcholinesterase inhibit
14 pendency, and withdrawal can occur after the prolonged administration of any agent used for sedation
17 he dose-dependent effects and the effects of prolonged administration of common pharmacologic agents
23 gh rate of severe adverse effects induced by prolonged administration of high doses of systemic corti
26 ers therapeutic effectiveness, necessitating prolonged administration of multiple doses that heighten
27 concentration in the urine samples after the prolonged administration of NFX using the MPG electrode.
32 To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long-acting ang
36 erance is a decreasing effect of a drug with prolonged administration of that drug or of a related (e
37 Dyskinesia, a motor complication caused by prolonged administration of the antiparkinsonian drug l-
44 ll arteritis (GCA) is effective but requires prolonged administration, resulting in adverse side effe
45 n intravenous delivery but may be limited by prolonged administration times and multiple injections.